ATE495239T1 - Zellen für adenovirusvektor- und proteinherstellung - Google Patents

Zellen für adenovirusvektor- und proteinherstellung

Info

Publication number
ATE495239T1
ATE495239T1 AT08743728T AT08743728T ATE495239T1 AT E495239 T1 ATE495239 T1 AT E495239T1 AT 08743728 T AT08743728 T AT 08743728T AT 08743728 T AT08743728 T AT 08743728T AT E495239 T1 ATE495239 T1 AT E495239T1
Authority
AT
Austria
Prior art keywords
protein production
cells
adenovirus vector
line
adenovirus
Prior art date
Application number
AT08743728T
Other languages
English (en)
Inventor
Imre Kovesdi
Original Assignee
Vectorlogics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vectorlogics Inc filed Critical Vectorlogics Inc
Application granted granted Critical
Publication of ATE495239T1 publication Critical patent/ATE495239T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0091—Purification or manufacturing processes for gene therapy compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material
    • C12N2710/10352—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Manufacturing & Machinery (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT08743728T 2007-03-09 2008-03-07 Zellen für adenovirusvektor- und proteinherstellung ATE495239T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89401807P 2007-03-09 2007-03-09
PCT/US2008/056198 WO2008112540A2 (en) 2007-03-09 2008-03-07 Cells for adenovirus vector and protein production

Publications (1)

Publication Number Publication Date
ATE495239T1 true ATE495239T1 (de) 2011-01-15

Family

ID=39743143

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08743728T ATE495239T1 (de) 2007-03-09 2008-03-07 Zellen für adenovirusvektor- und proteinherstellung

Country Status (5)

Country Link
US (1) US20090227031A1 (de)
EP (1) EP2132300B1 (de)
AT (1) ATE495239T1 (de)
DE (1) DE602008004476D1 (de)
WO (1) WO2008112540A2 (de)

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464764A (en) * 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
JPH08503855A (ja) * 1992-12-03 1996-04-30 ジェンザイム・コーポレイション 嚢胞性線維症に対する遺伝子治療
US6004941A (en) * 1993-06-14 1999-12-21 Basf Aktiengesellschaft Methods for regulating gene expression
CA2192442C (en) * 1994-06-10 2007-09-25 Imre Kovesdi Complementary adenoviral vector systems and cell lines
US5851806A (en) * 1994-06-10 1998-12-22 Genvec, Inc. Complementary adenoviral systems and cell lines
US6783980B2 (en) * 1995-06-15 2004-08-31 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
US6265212B1 (en) * 1995-06-15 2001-07-24 Introgene B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
PT833934E (pt) * 1995-06-15 2005-02-28 Crucell Holland Bv Sistemas de empacotamento para adenovivrus recombinente humano destinados a terapia genetica
US5972650A (en) * 1997-06-26 1999-10-26 Brigham And Women's Hospital Tetracycline repressor regulated mammalian cell transcription and viral replication switch
US6989264B2 (en) * 1997-09-05 2006-01-24 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
CA2320513A1 (en) * 1998-02-11 1999-08-19 Joseph T. Bruder Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors
US6670188B1 (en) * 1998-04-24 2003-12-30 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
WO1999057296A1 (en) * 1998-05-01 1999-11-11 Genzyme Corporation Partially deleted adenoviral vectors
US6291214B1 (en) * 1998-05-11 2001-09-18 Glaxo Wellcome Inc. System for generating recombinant viruses
US6855544B1 (en) * 1999-04-15 2005-02-15 Crucell Holland B.V. Recombinant protein production in a human cell
US6492169B1 (en) * 1999-05-18 2002-12-10 Crucell Holland, B.V. Complementing cell lines
US6913922B1 (en) * 1999-05-18 2005-07-05 Crucell Holland B.V. Serotype of adenovirus and uses thereof
AU5451300A (en) * 1999-05-28 2000-12-18 Mount Sinai School Of Medicine, The A novel packaging cell line for the rescue, production and titration of high-capacity adenovirus amplicon vectors
US6541245B1 (en) * 1999-09-23 2003-04-01 Genzyme Corporation Adenoviral helper vectors
US6579522B1 (en) * 2000-06-27 2003-06-17 Genvec, Inc. Replication deficient adenoviral TNF vector
US6682929B2 (en) * 2001-07-23 2004-01-27 Genvec, Inc. Adenovector complementing cells
US6677156B2 (en) * 2001-07-23 2004-01-13 Genvec, Inc. Non-adenoviral gene product-based complementing cells for adenoviral vectors
EP1425045A4 (de) * 2001-09-13 2004-11-10 Genvec Inc Adenoviraler vektor und relevantes system und verfahren zu seiner herstellung und verwendung
EP2277910A1 (de) * 2001-12-21 2011-01-26 Human Genome Sciences, Inc. Albumin Fusionsproteine
US7189561B2 (en) * 2004-09-21 2007-03-13 Advec, Inc. Production of adenovirus vectors with reduced levels of replication competent adenovirus contamination

Also Published As

Publication number Publication date
DE602008004476D1 (de) 2011-02-24
WO2008112540A3 (en) 2008-12-04
EP2132300A2 (de) 2009-12-16
EP2132300B1 (de) 2011-01-12
US20090227031A1 (en) 2009-09-10
WO2008112540A2 (en) 2008-09-18

Similar Documents

Publication Publication Date Title
CY1110734T1 (el) Μεθοδος παραγωγης μονιμων ανθρωπινων κυτταρικων σειρων
EA200901388A1 (ru) Повышение продуктивности растений путем комбинирования химических веществ с трансгенными модификациями
PH12013500360B1 (en) Pesticidal compositions
MX2019004378A (es) Edulcorante de estevia altamente soluble.
EP2516624A4 (de) Zelllinie 3m
MX339769B (es) Sistemas, metodos y composiciones para optimizar injertos enriquecidos con celulas y tejidos.
SG10201901417UA (en) Production of proteins in glutamine-free cell culture media
MX392247B (es) Composiciones detergentes.
MX380772B (es) 3-epimerasa.
CL2012000590A1 (es) Proceso para preparar w-transaminasa (r)-selectiva.
DK3421597T3 (da) System til chrysosporium lucknowense-proteinfremstilling
UA115022C2 (uk) Трансгенна рослина, яка містить нуклеїнову кислоту, що має виділену нуклеотидну послідовність, яка кодує модифіковану інтеїном ксиланазу
IN2012DN00933A (de)
SG195190A1 (en) Dispersion and detachment of cell aggregates
EP2215216A4 (de) Extrazelluläre matrix aus pluripotenten zellen
WO2012024573A3 (en) Compositions comrpising perivascular stem cells and nell-1 protein
CY1124624T1 (el) Μητρες οι οποιες περιεχουν εναν τροποποιημενο πολυσακχαριτη
MX337203B (es) Novedosas moleculas inhbidoras de jnk.
EA201300876A1 (ru) Мутантная целлобиогидролаза
DE602005024180D1 (de) Erzeugungssystem für brennstoffzellen des polymer-elektrolyttyps
CY1118539T1 (el) Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο
ATE490354T1 (de) Elektrode für membranelektrolysezellen
BR112014011943A2 (pt) plantas tolerantes à seca produzidas por modificação do locus stgx estadia-verde
WO2012175745A9 (en) Cell secreted proteins for the treatment of myocardial infarction
MX2022000516A (es) Metodos relacionados con celulas pluripotentes.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties